Treatment Registry
TR-0484 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Revel Health · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$199

Medication · Tirzepatide ODT, from-price, first month discounted$199

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide Injection, from-price, first month discounted

Tirzepatide Injection From $249 /mo First month $149

source

Per month$249Charged today$149
Tirzepatide ODT, from-price, first month discounted

Tirzepatide ODT From $199 /mo First month $149

source

Per month$199Charged today$149
Visit Revel Health

We earn nothing from this link. Revel Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll states except Alaska, Arkansas, Mississippi, New Jersey, and North Carolina
PrescriberAsynchronous review
Cancellation“What happens if I'm not approved? If a licensed provider determines that a program is not appropriate for you, you'll be notified and receive a full refund. Any subscription will be canceled, so there are no ongoing charges.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from myrevelhealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Clean per-product pricing for four SKUs: semaglutide injection, semaglutide ODT (orally-dissolving tablet, classified as sublingual since it melts rather than being swallowed), tirzepatide injection, and tirzepatide ODT. All state list on the homepage is an explicit served-list (44 states), not an exclusion, with the 5 unserved states named separately.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0484
Readings
1

Related records

What else Revel Health sells

All Revel Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Revel Health compounded tirzepatide (TR-0484). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0484

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.